শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Anexate is indicated for reversal of the centrally sedative effects of benzodiazepines. It should therefore be used in anaesthesia and intensive care in the following indications:In anaesthesia- Termination of general anaesthesia induced and maintained with benzodiazepines in inpatients. ... Read moreAnexate is indicated for reversal of the centrally sedative effects of benzodiazepines. It should therefore be used in anaesthesia and intensive care in the following indications:In anaesthesia- Termination of general anaesthesia induced and maintained with benzodiazepines in inpatients. Reversal of benzodiazepine sedation in short diagnostic and therapeutic procedures in both inpatients and outpatients. Reversal of paradoxical reactions due to benzodiazepines. In intensive care and in the management of unconsciousness of unknown origin- For the diagnosis and/or management of benzodiazepine overdose due to self-poisoning or accidental overdose. As a diagnostic measure in unconsciousness of unknown origin to differentiate between involvement of benzodiazepines, other medicines or drugs or brain damage. Anexate may also be used for specific reversal of the central effects of benzodiazepines in drug or medicine overdose (return to spontaneous respiration and consciousness in order to render intubation unnecessary or allow extubation)

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

Pregnancy & Breastfeeding

Pregnancy: Although high-dose studies of Flumazenil in animals and in-vitro systems have not pointed to mutagenic or teratogenic effects, or to any impairment of fertility, its safety in human pregnancy is not yet established. For this reason, it should only be used in pregnancy if the potential benefit is judged to outweigh any possible risk to the unborn child.

Breastfeeding: Flumazenil given parenterally for emergency reversal is not contraindicated during breastfeeding. High-dose animal studies have likewise shown no evidence that it impairs fertility.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: Flumazenil is recommended for intravenous (IV) use only and should be administered by an anaesthesiologist or an experienced physician. In anaesthesia: The recommended initial dose of Flumazenil is 0.2 mg, administered IV over 15 seconds. If the desired degree of consciousness is not obtained within 60 seconds, a second dose of 0.1 mg can be injected. This may be repeated at 60 second intervals where necessary, up to a total dose of 1 mg. The usual dose is 0.3 to 0.6 mg, but individual requirements may vary considerably, depending on the dose and duration of effect of the benzodiazepine administered and on patient characteristics. In intensive care and in the management of unconsciousness of unknown origin: The recommended initial dose of Flumazenil is 0.3 mg IV. If the desired level of consciousness is not obtained within 60 seconds, Flumazenil may be injected repeatedly until the patient awakes, up to a total dose of 2 mg. If drowsiness recurs, Flumazenil may be given as one or more bolus IV doses as above, or as an IV infusion of 0.1 to 0.4 mg per hour. The rate of infusion should be adjusted individually to the desired level of arousal. If repeated doses of Flumazenil do not bring a significant improvement in consciousness or respiratory function, a non benzodiazepine cause must be assumed. In the intensive care unit, in patients treated with high doses of benzodiazepines and/or for long periods, individually titrated injections of Flumazenil, given slowly, should not produce withdrawal symptoms. If unexpected symptoms occur, diazepam or midazolam can be carefully titrated intravenously according to the patient's response. Children above 1 year of age: For reversing conscious sedation induced with benzodiazepines in children above one year of age, the recommended initial dose is 0.01 mg/kg (up to 0.2 mg), administered IV over 15 seconds. If the desired level of consciousness is not obtained after an additional 45 seconds, further injections of 0.01 mg/kg (up to 0.2 mg) can be given and repeated at 60 second intervals where necessary, up to a maximum of four additional times, to a maximum total dose of 0.05 mg/kg or 1 mg, whichever is lower. The dose should be individualised based on the patient's response. No data are available on the safety and efficacy of repeated administration of Flumazenil to children for re sedation.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →